Illinois Appeals Court Affirms Dismissal Of Non-Brand Defendants In Zantac Case

( July 8, 2025, 3:30 PM EDT) -- CHICAGO — Claims against non-brand defendants in a woman’s case alleging that the heartburn drug Zantac and its generic equivalent, ranitidine, caused her to develop colon cancer were properly dismissed, an Illinois appeals court affirmed....